Clinical Trial Update: Fixed Dose Combination Versus Free Combination of Tiotropium and Olodaterol in COPD [Phase 4]

View source ↗

Summary

Phase 4 trial comparing fixed-dose combination of tiotropium/olodaterol versus free combination in COPD; results posted after completion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Obstructive Pulmonary Disease

Drugs mentioned

• Tiotropium/olodaterol fixed-dose combination (tiotropium/olodaterol)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Pulmonary Disease, Chronic Obstructive | Phase 4 | Status: COMPLETED | Results posted: 2018-08-17